- Tipo NewsRICERCA PARTNER
- FonteSIMPLER
- Del
The solution provides the first regulatory-qualified digital endpoint : "SV95C", a measure of the patient's maximal gait speed.
It also provides a number of endpoints assessing lower-limb and upper-limb motricity and has supported dozens of clinical trials.
In relevant diseases, the higher sensitivity of the SME's digital endpoints, compared with traditional controlled-environment clinical outcomes, can allow the measure of a therapy's efficacy to reach statistical significance with a smaller number of patients and shorter follow-up durations, thus accelerating the clinical development of the therapy.
The project call "HORIZON-HLTH-2025-01-TOOL-05 : boosting the translation of biotech research into innovative health therapies" aims to speed up the development of innovative biotechnology-based therapies by supporting Phase I/II clinical trials.
The SME's solution would therefore fit perfectly in the scope of this project call. It is seeking to join a consortium led by a biotech SME with a Phase I/II clinical trial project in a motricity-affecting disease.
Codice di riferimento della ricerca partner: RDRFR20250602009
---
Per ottenere ulteriori informazioni finalizzate ad attivare una partnership, segnaliamo che è possibile:
- se localizzati in Emilia Romagna, compilare il modulo per manifestare il proprio interesse
- se localizzati in altre regioni d'Italia, individuare l'ente di riferimento per la propria regione sul sito ufficiale di Enterprise Europe Network riportando, in ogni caso, il codice di riferimento.
Per pubblicare la vostra ricerca partner nel database della rete Enterprise Europe Network è possibile contattare l’ente di riferimento della rete EEN. Qualora localizzati in Emilia-Romagna potete contattare ART-ER all’indirizzo e-mail simpler@art-er.it
